{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:55:22Z","timestamp":1776128122727,"version":"3.50.1"},"reference-count":31,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/mmr.2017.6197","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T10:33:24Z","timestamp":1486982004000},"page":"1837-1846","source":"Crossref","is-referenced-by-count":12,"title":["Identification of miR-30b as an oncogene in renal cell carcinoma"],"prefix":"10.3892","volume":"15","author":[{"given":"Lu","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoting","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"key20180108014947_b1-mmr-15-04-1837","first-page":"886","article-title":"Survival and complications of skeletal reconstructions after surgical treatment of bony metastatic renal cell carcinoma","volume":"41","author":"Laitinen","year":"2015","journal-title":"EJSO the Journal Cancer Surgery"},{"key":"key20180108014947_b2-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180108014947_b3-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1102\/1470-7330.2013.9035","article-title":"Metastatic renal cell cancer","volume":"13","author":"Rasmussen","year":"2013","journal-title":"Cancer Imaging"},{"key":"key20180108014947_b4-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncponc0479","article-title":"Nonmetastatic renal-cell carcinoma: Is it really possible to define rational guidelines for post-treatment follow-up?","volume":"3","author":"Rouvi\u00e8re","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"key20180108014947_b5-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: A population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"key20180108014947_b6-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1097\/MD.0000000000001048","article-title":"High ER\u03b136 Expression level and membrane location predict poor prognosis in renal cell carcinoma","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key20180108014947_b7-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s13277-014-2925-6","article-title":"Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180108014947_b8-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urolonc.2008.10.021","article-title":"MicroRNAs and cancer: Current state and future perspectives in urologic oncology","volume":"28","author":"Schaefer","year":"2010","journal-title":"Urol Oncol"},{"key":"key20180108014947_b9-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.7314\/APJCP.2014.15.20.8893","article-title":"Association of miR-193b down-regulation and mir-196a up-regulation with clinicopathological features and prognosis in gastric Cancer","volume":"15","author":"Mu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108014947_b10-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.archoralbio.2012.04.002","article-title":"Amplification and up-regulation of microRNA-30b in oral squamous cell cancers","volume":"57","author":"Shao","year":"2012","journal-title":"Arch Oral Biol"},{"key":"key20180108014947_b11-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clinbiochem.2014.11.020","article-title":"Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer","volume":"48","author":"Lu","year":"2015","journal-title":"Clin Biochem"},{"key":"key20180108014947_b12-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1007\/s11033-014-3439-4","article-title":"Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis","volume":"41","author":"Qiao","year":"2014","journal-title":"Mol Biol Rep"},{"key":"key20180108014947_b13-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12935-015-0236-7","article-title":"microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer","volume":"15","author":"Chen","year":"2015","journal-title":"Cancer Cell Int"},{"key":"key20180108014947_b14-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/BJ20131535","article-title":"miR-30b regulates migration and invasion of human colorectal cancer via SIX1","volume":"460","author":"Zhao","year":"2014","journal-title":"Biochem J"},{"key":"key20180108014947_b15-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"e106049","DOI":"10.1371\/journal.pone.0106049","article-title":"miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"key20180108014947_b16-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00432-015-1927-0","article-title":"A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma","volume":"141","author":"Ge","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108014947_b17-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"e25787","DOI":"10.1371\/journal.pone.0025787","article-title":"MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels","volume":"6","author":"Wulfken","year":"2011","journal-title":"PLoS One"},{"key":"key20180108014947_b18-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108014947_b19-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2217\/imt.14.41","article-title":"Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: A pooled meta-analysis","volume":"6","author":"Wang","year":"2014","journal-title":"Immunotherapy"},{"key":"key20180108014947_b20-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.febslet.2011.08.014","article-title":"miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells","volume":"585","author":"Liu","year":"2011","journal-title":"FEBS Lett"},{"key":"key20180108014947_b21-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/1471-2407-14-703","article-title":"MicroRNA-30b\/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18","volume":"14","author":"Zhong","year":"2014","journal-title":"BMC Cancer"},{"key":"key20180108014947_b22-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.3748\/wjg.v21.i31.9337","article-title":"MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer","volume":"21","author":"Tian","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20180108014947_b23-mmr-15-04-1837","first-page":"32","article-title":"Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer","volume":"4","author":"Mahdavinezhad","year":"2015","journal-title":"Int J Mol Cell Med"},{"key":"key20180108014947_b24-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"e6159","DOI":"10.1371\/journal.pone.0006159","article-title":"Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma","volume":"4","author":"Lu","year":"2009","journal-title":"PLoS One"},{"key":"key20180108014947_b25-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00345-010-0633-4","article-title":"Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma","volume":"29","author":"Heinzelmann","year":"2011","journal-title":"World J Urol"},{"key":"key20180108014947_b26-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.3760\/cma.j.issn.0366-6999.20131112","article-title":"miR-30b and miR-30c expression predicted response to tyrosine kinase inhibitors as first line treatment in non-small cell lung cancer","volume":"126","author":"Gu","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"key20180108014947_b27-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/path.4309","article-title":"MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2","volume":"232","author":"Liao","year":"2014","journal-title":"J Pathol"},{"key":"key20180108014947_b28-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1182\/blood-2012-04-423004","article-title":"The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis","volume":"120","author":"Bridge","year":"2012","journal-title":"Blood"},{"key":"key20180108014947_b29-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.leukres.2013.09.015","article-title":"Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients","volume":"37","author":"Fuster","year":"2013","journal-title":"Leuk Res"},{"key":"key20180108014947_b30-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"19729","DOI":"10.3390\/ijms151119729","article-title":"Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma","volume":"15","author":"Li","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20180108014947_b31-mmr-15-04-1837","doi-asserted-by":"crossref","first-page":"e31422","DOI":"10.1371\/journal.pone.0031422","article-title":"Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells","volume":"7","author":"Ichikawa","year":"2012","journal-title":"PLoS One"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6197\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T12:47:31Z","timestamp":1719060451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,13]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/mmr.2017.6197"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6197","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}